Trial · NCT03446040
Participant flow56
How many started, completed or left each group, period by period.
1 to 20 of 56
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Part A: BMS-986258 8 mg | 3 | |
| Overall Study | STARTED | Part A: BMS-986258 24 mg | 3 | |
| Overall Study | STARTED | Part A: BMS-986258 72 mg | 4 | |
| Overall Study | STARTED | Part A: BMS-986258 200 mg | 4 | |
| Overall Study | STARTED | Part A: BMS-986258 480 mg | 4 | |
| Overall Study | STARTED | Part A: BMS-986258 800 mg | 9 | |
| Overall Study | STARTED | Part A: BMS-986258 1200 mg | 3 | |
| Overall Study | STARTED | Part A: BMS-986258 1600 mg | 5 | |
| Overall Study | STARTED | Part A: BMS-986258 2400 mg | 8 | |
| Overall Study | STARTED | Part B: BMS-986258 480 mg + NIVO 480 mg | 4 | |
| Overall Study | STARTED | Part B: BMS-986258 800 mg + NIVO 480 mg | 11 | |
| Overall Study | STARTED | Part B: BMS-986258 1200 mg + NIVO 480 mg | 4 | |
| Overall Study | STARTED | Part B: BMS-986258 1600 mg + NIVO 480 mg | 15 | |
| Overall Study | STARTED | Part A1: BMS-986258 1200 mg + ENHANZE | 15 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 8 mg | 0 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 24 mg | 0 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 72 mg | 0 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 200 mg | 0 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 480 mg | 0 | |
| Overall Study | Transitioned From Part A1 | Part A: BMS-986258 800 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03446040/flow